Dr. Ross on the Role of the Microbiome in CRC

Video

In Partnership With:

Howard M. Ross, MD, discusses the role of the microbiome colorectal cancer.

Howard M. Ross, MD, colon and rectal surgeon, chair of surgery, surgeon in chief, Hackensack University Medical Center, professor, chair, Department of Surgery, Hackensack Meridian School of Medicine, discusses the role of the microbiome colorectal cancer (CRC).

The exploration of the role of the microbiome and how the makeup of bacteria in the colon affect outcomes is an exciting frontier in CRC, Ross explains. As rates of CRC in younger patients have dramatically increased, researchers have struggled to identify exact explanations; however, a combination of the environment and how that affects the microbiome could be a factor, Ross says.

Many health aspects for humans are affected by social determinants, and these need to be a focus for colon and rectal health, Ross continues. Research is ongoing to evaluate how the environment plays a role in the development of CRC, Ross concludes.

Related Videos
Katrina S. Pedersen, MD, MS, associate professor, John T. Milliken Department of Medicine, Division of Oncology, Medical Oncology program leader, cofounder, Young Onset Colorectal Cancer Program, Washington University School of Medicine in St. Louis, Siteman Cancer Center
Debu Tripathy, MD
Changchun Deng, MD, PhD
Joaquim Bellmunt, MD, PhD
Timothy Yap, MBBS, PhD, FRCP
Parul N Barry, MD,
Ramez Kouzy, MD, MD Anderson
Bernard A. Fox, PhD
Bradley R. Corr, MD, associate professor, LeBert Suess Family Endowed Professor in Ovarian Cancer Research, gynecologic oncology team, the University of Colorado Anschutz Medical Campus